Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Frontiers in Medicine|April 18, 2022
Case Report: Chronic Active Epstein-Barr Virus Infection With Subcutaneous Nodules and Systemic DamageHuating Luo, Zhe Yuan, Bo Qin
Reviews in Medical Virology|December 6, 2024
Epigenetic Targeting for Controlling Persistent Neurotropic Infections Caused by Borna Virus and HIVYadi Li, Huating Luo, Hao Pang, et al.
Infection and Drug Resistance|June 17, 2024
Infective Endocarditis Due to High-Level Gentamicin-Resistant <i>Enterococcus faecalis</i> Complicated Multisystemic Complications in an Elderly PatientKexin Tong, Huating Luo, Haifeng Dai, et al.
Infection and Drug Resistance|August 12, 2022
Disseminated Cryptococcal Infection of the Lumbar Spine in an Immunocompetent ManRui Wang, Huating Luo, Xiaojuan Xin, et al.
IEEE Journal of Biomedical and Health Informatics|October 16, 2024
Attention-Guided 3D CNN With Lesion Feature Selection for Early Alzheimer's Disease Prediction Using Longitudinal sMRIJinwei Liu, Yashu Xu, Yi Liu, et al.
Biochemical and Biophysical Research Communications|June 17, 2025
Multi-omics approaches to explore the therapeutic mechanism for ginsenoside Rg1 against MASLDZhijian Wang, Yinuo Wang, Jia Zhang, et al.
Biochemical Pharmacology|March 16, 2026
Ginsenoside Rg1 alleviates MASH by targeting GLS2 to enhance PINK1/Parkin-mediated mitophagy and improve mitochondrial functionZhijian Wang, Yinuo Wang, Peiyun Peng, et al.
Journal of Viral Hepatitis|June 20, 2020
Intrahepatic T helper 17 cells recruited by hepatitis B virus X antigen-activated hepatic stellate cells exacerbate the progression of chronic hepatitis B virus infectionHongbin Zhang, Xiong Yan, Cheng Yang, et al.
Journal of Hepatocellular Carcinoma|October 2, 2023
Development and Validation of a Novel Prognosis Model Based on a Panel of Three Immunogenic Cell Death-Related Genes for Non-Cirrhotic Hepatocellular CarcinomaJiaojiao Gong, Renjie Yu, Xiaoxia Hu, et al.
Journal of Cancer Research and Clinical Oncology|March 26, 2024
Risk of HBV reactivation in HCC patients undergoing combination therapy of PD-1 inhibitors and angiogenesis inhibitors in the antiviral eraRui Wang, Guili Tan, Dingjia Lei, et al.
Pageof 2